Evidence map›Paper›PMID 36944962›Full record

ArticleBMC urology2023

Clinical features and Surgical Outcome of Clear Cell Papillary Renal Cell Tumor: result from a prospective cohort.

Si Hyun Kim, Jang Hee Han, Seung-Hwan Jeong, Hyeong Dong Yuk, Ja Hyeon Ku, Cheol Kwak, Hyeon Hoe Kim, Kyung Chul Moon, Chang Wook Jeong

Open access · goldFull text readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC urology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Si Hyun KimDepartment of Urology, Seoul National University Hospital, Seoul, Korea.
Jang Hee HanDepartment of Urology, Seoul National University Hospital, Seoul, Korea.
Seung-Hwan JeongDepartment of Urology, Seoul National University Hospital, Seoul, Korea.ORCID http://orcid.org/0000-0002-8076-3643
Hyeong Dong YukDepartment of Urology, Seoul National University Hospital, Seoul, Korea.
Ja Hyeon KuDepartment of Urology, Seoul National University Hospital, Seoul, Korea.
Cheol KwakDepartment of Urology, Seoul National University Hospital, Seoul, Korea.ORCID http://orcid.org/0000-0002-1987-2111
Hyeon Hoe KimDepartment of Urology, Seoul National University Hospital, Seoul, Korea.
Kyung Chul MoonDepartment of Pathology, Seoul National University Hospital, Seoul national University College of medicine, Seoul, Korea.
Chang Wook JeongDepartment of Urology, Seoul National University Hospital, Seoul national University College of medicine, 101 Daehak-ro, Joungno-gu, Seoul, 03080, Korea. drboss@snu.ac.kr.
Seoul National University · KRSeoul National University Hospital · KRSoonchunhyang University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundClear cell papillary renal cell tumor (CCPRCT) was first reported in 2006 a patient with end stage renal disease. After that it was discovered in the kidney without end stage renal disease in the 2010s and started to be mentioned in pathology and urology. The incidence of CCPRCT is low and most of it is discovered incidentally, so there is a lack of reports on clinical characteristics and surgical outcome.

methodsThis study used clinical data from the Seoul National University Prospectively Enrolled Registry for Renal Cell Carcinoma-Nephrectomy (SUPER-RCC-Nx). Between August 2016 and July 2022, patients who underwent radical or partial nephrectomy with clear cell papillary RCC with pathological finding were included in this study. All patients' pathologic reports were reviewed by 1 pathologist. Clinical characteristics and surgical outcomes were presented through descriptive statistics, and Kaplan-Meier curve used for survival analysis.

resultsOf the 2057 patients, CCPRCT was reported in 36 patients (1.8%). The median follow up period was 26.8 months. The median age was 67 years, and there were 10 females and 26 males. The median tumor size was 1.2 cm. Twenty-nine patients underwent partial nephrectomy. Seven patients with end-stage renal disease underwent radical nephrectomy. The median operative time for patients who underwent partial nephrectomy was 97.5 min and the estimated blood loss was 100 cc. The median hospital days was 4 and 30-day complications were 2 cases with clavien-dindo classification III or higher. During the follow-up period, there was no recurrence and cancer specific mortality.

conclusionsThe size of CCPRCT was small and there was no advanced stage at that time of diagnosis. There was no recurrence or cancer specific mortality during the follow-up period. A multi-center study with a large scale is needed in the future.

trial registrationSeoul National University Hospital (SNUH) Institutional Review Board (IRB) (approval number: 2210-126-1371).

Indexed as

Carcinoma, Renal CellKidney Failure, ChronicKidney NeoplasmsAgedFemaleHumansMaleNephrectomyProspective StudiesRetrospective StudiesTreatment OutcomeNephrectomyPathologyRenal cell carcinomaSmall renal massSurgical

Identifiers

PMID36944962
PMCPMC10031917
OpenAlexW4328089118

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read33
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.